Friday, April 13, 2012
Pacira Pharmaceuticals Inc., of Parsippany, N.J., priced an underwritten public offering of 6 million shares of common stock at $9.75 per share, a 3.6 percent discount to Wednesday's closing price. The offering will yield gross proceeds of about $58.5 million and will close on or about April 17.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.